Today 2026.10.07 D-End
Today 
|
Satellite Symposium 3 Sep. 19 (Sat), 08:30-09:00 |
Room C (2F) |
|
|---|---|---|
| Chair(s) | Seok Lee (Ewha Womans University College of Medicine, Korea) | |
Ph-Positive ALL in 2026: From Precision Immuno-Targeted Therapy to Transplantation
College of Medicine, The Catholic University of Korea, Korea
|
Joint Symposium 6 (TSBMT-KSBMT) Endothelial Dysfunction Syndromes after Allogeneic HSCT: From SOS/VOD and TA-TMA to CLS/ES and PRES Sep. 19 (Sat), 09:00-10:00 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) Hakan Göker (Hacettepe University, Türkiye) |
|
Hepatic, Pulmonary, and Systemic Endothelial Injury after Allogeneic HSCT: SOS/VOD, Capillary Leak/Engraftment Syndrome, and IPS/DAH
Hacettepe University, Türkiye
Transplant-Associated Thrombotic Microangiopathy, PRES, and GVHD-Related Endothelial Injury after Allogeneic HSCT
Korea University College of Medicine, Korea
|
[OP01] Oral Presentation 9 |
Room C (2F) |
||
|---|---|---|---|
| Date & Time | Sep. 19 (Sat), 09:00-10:00 | ||
| Chair(s) |
Jae Min Lee (Pusan National University School of Medicine, Korea) Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Real-World Outcomes of Chimeric Antigen Receptor T-Cell Therapy in Pediatric B-Cell Acute Lymphoblastic Leukemia: Role of Consolidative Hematopoietic Cell Transplantation Jae Won Yoo (College of Medicine, The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Longitudinal Immune Reconstitution and Viral Landscape under Letermovir Prophylaxis in Pediatric Allogeneic HSCT Qingwei Wang (Children's Hospital of Soochow University, China) | ||
| 09:20-09:30 | Outcomes of Ex Vivo T Cell Depleted Haploidentical HSCT in Children with Acute Lymphoblastic Leukemia Sung Han Kang (University of Ulsan College of Medicine, Korea) | ||
| 09:30-09:40 | Comparative Outcomes of Carboplatin-Etoposide-Melphalan and Busulfan-Melphalan as High-Dose Chemotherapy for High-Risk Neuroblastoma: An International Two-Center Study from Taiwan and Korea Jin Kyung Suh (Seoul National University College of Medicine, Korea) | ||
| 09:40-09:50 | Haploidentical Transplantation with Unrelated Cord Blood Support (SZ-19-TM Protocol) Improves Outcomes in Pediatric Transfusion-Dependent Thalassemia: A Large-Scale Retrospective Cohort Study Ruihao Zheng (Shenzhen Children's Hospital, China) | ||
| 09:50-10:00 | Pre-Freezing Hematocrit Independently Associated with Post-Thaw CD34+ Cell Viability in Cryopreserved Autologous Peripheral Blood Stem Cell Products from Pediatric Neuroblastoma Patients Thi Thanh Lam Nguyen (National Children's Hospital, Vietnam) | ||
|
[OP02] Oral Presentation 10 |
Room D (2F) |
||
|---|---|---|---|
| Date & Time | Sep. 19 (Sat), 09:00-10:00 | ||
| Chair(s) |
Ho Sup Lee (Kosin University College of Medicine, Korea) Jee Hyun Kong (Wonju Severance Christian Hospital, Korea) |
||
| Speaker(s) | 09:00-09:10 | Single-Cell Transcriptomic and TCR Repertoire Profiling Defines an Exhaustion-Associated CD39+ CD8+ T-Cell State in the Bone Marrow of Acute Lymphoblastic Leukemia Nayeon Seong (College of Medicine, The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Assessment of CRS-Related Toxicity of BCMA CAR-MILs Using the NSG-SGM3 Model Manh Cuong Vo (Chonnam National University Medical School, Korea) | ||
| 09:20-09:30 | Development of Bispecific CAR- T Cells Targeting Mesothelin (MSLN) and Disialoganglioside 2 (GD2) for Neuroblastoma Nayoung Kim (University of Ulsan College of Medicine, Korea) | ||
| 09:30-09:40 | First-in-Human Phase 1 Study of GF-CART01, a Non-Viral CD19/CD20 Dual-Targeting CAR T Generated Using the qCART Platform in Relapsed/Refractory B-Cell Malignancies Shang-Ju Wu (National Taiwan University Hospital, Taiwan) | ||
| 09:40-09:50 | Exploring the Therapeutic Potential of CAR-MSCs Targeting the OX40/OX40L Axis in Immune Disorders Byungchan Kim (Sungkyunkwan University School of Medicine, Korea) | ||
| 09:50-10:00 | First Korean Report of Donor-Derived Multivirus-Specific T-Cell Therapy for Refractory BK Virus Hemorrhagic Cystitis after Pediatric Haploidentical Hematopoietic Cell Transplantation Jae Won Yoo (College of Medicine, The Catholic University of Korea, Korea) | ||
|
Scientific Session 9 Insights on GVHD Prediction, Prevention and Management Sep. 19 (Sat), 10:10-11:40 |
Room A (1F) |
|
|---|---|---|
| Chair(s) |
Hoon Kook (Chonnam National University Medical School, Korea) Byung Sik Cho (College of Medicine, The Catholic University of Korea, Korea) |
|
Pediatric Chronic GVHD: From Biological Insights to Clinical Management
BC Children's Hospital Research Institute, Canada
Immunobiology of GVHD Prevention
Hokkaido University, Japan
Microbiome and GvHD Following Allogeneic HSCT
University of Ulsan College of Medicine, Korea
|
Scientific Session 10 Immune Effector Cell Therapy in Lymphoid Malignancies: From Pivotal Trials to Real-World Practice Sep. 19 (Sat), 10:10-11:40 |
Room C (2F) |
|
|---|---|---|
| Chair(s) |
Jin Seok Kim (Yonsei University College of Medicine, Korea) Young Rok Do (Keimyung University School of Medicine, Korea) |
|
Integrating MRD into CAR T-Cell Therapy for ALL: From Patient Selection to Post-Treatment Intervention
Memorial Sloan Kettering Cancer Center, USA
Sequencing Cellular Therapy in Multiple Myeloma: Lessons from Trials and Real-World Practice
Medical College of Wisconsin, USA
Real-World CAR‑T Experience in LBCL
College of Medicine, The Catholic University of Korea, Korea
|
Nursing Session 2 KOR Multidisciplinary Approach to Hematopoietic Stem Cell Transplantation Patients II & Thirty Years of Hematopoietic Stem Cell Transplant Nursing: Past, Present and Future Sep. 19 (Sat), 10:10-11:10 |
Room D (2F) |
|
|---|---|---|
| Chair(s) | Heejun Kim (Samsung Medical Center, Korea) | |
Radiotherapy in Hematologic Malignancies and Stem Cell Transplantation
National Cancer Center, Korea
Restoring Normal Life for Hematology Patients
College of Medicine, The Catholic University of Korea, Korea
